1. Role: Associate Dean. Scope: College. Description: Lead research enterprise of the College of Pharmacy. Represent the College at the HSC level. Mentor researchers. Date: 2020.
Vibhudutta Awasthi, Ph.D.
Professor and Associate Dean for Research
Pharmaceutical Sciences
Phone (405) 271-6593 x47331
Fax (405) -271-7505
Office CPB 309
Summary
My research interests are in the development of radiopharmaceuticals, small animal imaging and use of radiological imaging techniques to answer physiological questions. My current research focuses on the development of liposome encapsulated hemoglobin as an artificial oxygen carrier and he is studying cerebral oxygen metabolism using positron emission tomography. I am a board certified nuclear pharmacist with expertise in areas related to drug delivery, formulation development, nuclear pharmacy and small animal nuclear imaging.
Publications & Presentations
- 51. Anzellotti, A, Bailey J, Ferguson D, McFarland A, Bochev P, Andreev G, Awasthi V, Brown-Proctor C. Automated production and quality testing of [18F]labeled radiotracers using the BG75 system. J Radional Nucl Chem. 2015; 305 : 387-401
52. Yadav V R, Hussain A, Jun X, Kosanke S, Awasthi V. The salutary effects of diphenyldifluoroketone EF24 in liver of a rat hemorrhagic shock model. Scand J Trauma Resus & Emergency Medicine. 2015; 23 : 8
53. Awasthi V. Liposomes modified with superhydrophilic polymer-linked to a non-phospholipid anchor exhibit reduced complement activation and enhanced circulation. J Pharm Sci. 2015; 104 : 114-123
54. Kasus-Jacobi A, Nag O, Awasthi V, Babizhayev M, Pereira A. Investivating carcinine transport and the expression profile of transporter genes in human corneal epithelial cells. Springer. 2015
55. Gopal P, Hedrik A, January S, Galbraith W, Awasthi V, Gali H. Pathuri Gopal, Hedrik AF, January S*, Galbraith W, Awasthi V, Arnold CD, Cowley BD, Gali H. Synthesis and in vivo evaluation of gallium-68 labeled glycine and hippurate conjugates for PET renography. J. Label Compd. Radiopharm 2015;58:14–19. 2015
Grants
- 1. Mechanism of F-18-fluorodeoxyglucarate accrual in myocardial injury. NHLBI. Start Date: 2024. End Date: 2029.
2. Developing PPARγ acetylation inhibitor for the treatment of aging-related conditions. NIH. Start Date: 2021. End Date: 2026.
3. Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment. NIH. Start Date: 2021. End Date: 2026.
4. SBIR Phase I: Early-Stage Development of GPPD for Fatty Liver. NIH.
5. Surfactant protein-A regions as TLR4-immunomodulators. NIH. Start Date: 2017. End Date: 2023.
Awards and Honors
- 6. Sandra K and David L Gilliland Chair in Nuclear Pharmacy . Date: 2012.
7. Indo-American Society of Nuclear Medicine. President. Date: 2010.
Education
- 1. Degree: Ph D. Sanjay Gandhi Postgraduate Institute of Medical Sciences . Date: 1994.
2. Degree: M. Pharm.. Dr. Hari Singh Gour Vishwavidyalaya, Sagar (Formerly, University of Sagar). Date: 1990.
3. Degree: B. Pharm. Dr. Hari Singh Gour Vishwavidyalaya, Sagar (Formerly, University of Sagar). Date: 1988.
Administrative Assignments
2. Role: Director. Scope: University. Description: Direction and conduct of nuclear imaging services for biomedical investigators; Production of PET radiotracers for preclinical imaging and preparation for regulatory compliance for clinical applications; Consultations with researchers about imaging and tracer applications. Date: 2007.
External Connections and Partnerships
no results